All Stories

  1. The galectin-3/NLRP3 inflammasome axis: A unifying mechanism linking insomnia and heart failure
  2. The Pullback Pressure Gradient: Transforming Invasive Coronary Physiology from Lesion Assessment to Disease Pattern Characterization—A Perspective
  3. Various GLP-1 Receptor Agonist Preference Use with a Special Focus on Oral and Subcutaneous Forms in Poland
  4. Novel therapies for lowering low-density lipoprotein levels for atherosclerotic cardiovascular disease prevention: reaching the target where others have failed
  5. Inflammation as a Foundational Cardiovascular Risk Factor: Limitations and Context of the Zuo et al. Study
  6. Long-Term Outcomes After Myocardial Infarction in Young Adults: The Unseen Impact of Delays, Nonatherosclerotic Factors, and Subgroup Vulnerabilities
  7. A call for caution: interpreting myocardial infarction outcomes in inflammatory joint disease
  8. Age-related sex differences in intensive care treatment and outcomes. Comment on Br J Anaesth 2025
  9. The First Ten Minutes: Sex Disparities in Myocardial Infarction Begin at the Door
  10. Letter to the editor: “Structured team response and sex-based mortality gaps in acute pulmonary embolism: Conflicting evidence and future directions”
  11. The Irreversible March of Time: Ischemic Delay and Impact on Outcomes in ST-Segment Elevation Myocardial Infarction
  12. High Post–Transcatheter Aortic Valve Replacement Gradients: Not a Direct Predictor of Valve Deterioration
  13. Persistently low initiation of GLP-1 receptor agonists for weight management in individuals without diabetes in Poland: a major unmet need
  14. Addressing gender disparities in cardiovascular care: insights from the Polish national clinical registry
  15. Distinct clinical phenotypes of delirium in the cardiac intensive care unit: Moving beyond a single diagnostic entity
  16. Managing Acute Coronary Syndromes in Older Adults: Challenges and Registry Insights
  17. Regarding “Modifications of coronary plaque phenotype on lipid-lowering therapies and risk of cardiovascular events”: a compelling hypothesis warranting cautious interpretation
  18. Anthracyclines as diagnostic stressors: mitophagy signaling and hidden cardiac vulnerability
  19. Beyond traditional risk factors: the need for comprehensive phenotyping in young acute myocardial infarction patients
  20. Context-dependent nature of the obesity paradox in cardiac events
  21. Microvascular Function and Discordance in Physiology‐Guided PCI: Correlation or Causation?
  22. Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk
  23. In-Hospital Levels of Circulating MicroRNAs as Potential Predictors of Left Ventricular Remodeling Post-Myocardial Infarction
  24. The Impact of Age on the Physiological Assessment of Borderline Coronary Stenoses
  25. Comparison of Fractional Flow Reserve with Resting Non-Hyperemic Indices in Patients with Coronary Artery Disease
  26. Impact of COVID-19 Pandemic on Patients with ST-Segment-Elevation Myocardial Infarction Complicated by Out-of-Hospital Cardiac Arrest
  27. Knowledge and Prevalence of Risk Factors for Coronary Artery Disease in Patients after Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting
  28. Frailty as a Predictor of In-Hospital Outcome in Patients with Myocardial Infarction
  29. Safety and Efficacy of Four Different Diagnostic Catheter Curves Dedicated to One-Catheter Technique of Transradial Coronaro-Angiography—Prospective, Randomized Pilot Study. TRACT 1: Trans RAdial CoronaryAngiography Trial 1
  30. Balloon Aortic Valvuloplasty for Severe Aortic Stenosis as Rescue or Bridge Therapy
  31. Treatment Delay and Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction during the COVID-19 Pandemic
  32. Percutaneous coronary intervention during on- and off-hours in patients with ST-segment elevation myocardial infarction
  33. The Usefulness of [18F]F-Fluorodeoxyglucose and [18F]F-Sodium Fluoride Positron Emission Tomography Imaging in the Assessment of Early-Stage Aortic Valve Degeneration after Transcatheter Aortic Valve Implantation (TAVI)—Protocol Description and Prelimi...
  34. Direct Rapid Left Ventricular Wire Pacing during Balloon Aortic Valvuloplasty
  35. Calcium Pattern Assessment in Patients with Severe Aortic Stenosis Via the Chou’s 5-Steps Rule
  36. Prevalence and Predictors of Coronary Artery Perforation During Percutaneous Coronary Interventions (from the ORPKI National Registry in Poland)
  37. Radial Approach Expertise and Clinical Outcomes of Percutanous Coronary Interventions Performed Using Femoral Approach
  38. Hypertrophic Cardiomyopathy: The Time-Synchronized Relationship between Ischemia and Left Ventricular Dysfunction Assessed by Highly Sensitive Troponin I and NT-proBNP
  39. Hospitalization Length after Myocardial Infarction: Risk-Assessment-Based Time of Hospital Discharge vs. Real Life Practice
  40. Association of Inadequately Low Left Ventricular Mass with Enhanced Myocardial Contractility in Severe Degenerative Aortic Stenosis
  41. Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study
  42. Impact of On-Site Surgical Backup on Periprocedural Outcomes of Primary Percutaneous Interventions in Patients Presenting With ST-Segment Elevation Myocardial Infarction (From the ORPKI Polish National Registry)
  43. Impact of Pre-procedural Cerebrovascular Events on Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis
  44. Impact of chronic obstructive pulmonary disease and frailty on long-term outcomes and quality of life after transcatheter aortic valve implantation
  45. Predictors of in-hospital effectiveness and complications of rotational atherectomy (from the ORPKI Polish National Registry 2014-2016)
  46. In-hospital and long-term outcomes of percutaneous balloon aortic valvuloplasty with concomitant percutaneous coronary intervention in patients with severe aortic stenosis
  47. An interesting case of a self-apposing stent implantation in an aneurysmatically dilated artery in acute myocardial infarction with high quality optical coherence tomography images
  48. Determinants of stroke following percutaneous coronary intervention in acute myocardial infarction (from ORPKI Polish National Registry)
  49. The impact of multiple stent implantation in the infarct-related artery on one-year clinical outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Data from the Polish NRDES Registry
  50. Acute and long-term outcomes of percutaneous balloon aortic valvuloplasty for the treatment of severe aortic stenosis
  51. Decreased carotid and vertebral arterial blood-flow velocity in response to orthostatic unload in patients with severe aortic stenosis
  52. Twelve-Month Quality of Life Improvement and All-Cause Mortality in Elderly Patients Undergoing Transcatheter Aortic Valve Replacement
  53. Impact of Coronary Artery Disease Burden on 12-Month Mortality of Patients After Transcatheter Aortic Valve Implantation
  54. Assessment of quality of life in patients after surgical and transcatheter aortic valve replacement
  55. Circulatory support with Impella CP device during high-risk percutaneous coronary interventions: initial experience in Poland
  56. Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry
  57. Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation
  58. No clinical benefit from manual thrombus aspiration in patients with non-ST-elevation myocardial infarction
  59. Patient profile and periprocedural outcomes of bioresorbable vascular scaffold implantation in comparison with drug-eluting and bare-metal stent implantation. Experience from ORPKI Polish National Registry 2014–2015
  60. The successful retrieval of a broken guide wire from the diagonal branch of the left anterior descending coronary artery complicated by partial stent rolling
  61. Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non–ST-Elevation Myoc...
  62. A 24-year-old male with acute coronary syndrome due to the circumflex coronary artery thrombosis. Diagnostic challenge in everyday practice
  63. A response to “The importance of vasodilator therapy before or during angiography, is ICD necessary or not?” by Tamer Kırat and Nuri Köse
  64. Effect of introducing a regional 24/7 primary percutaneous coronary intervention service network on treatment outcomes in patients with ST segment elevation myocardial infarction
  65. Impact of coronary artery disease presence on the long-term follow-up of carotid artery stenting
  66. Recurrent coronary vasospasm-induced acute coronary syndrome complicated by cardiac arrest
  67. Mesh-Covered Embolic Protection Stent Implantation in ST-Segment–Elevation Myocardial Infarction
  68. Complete infarct-related artery revascularization in acute myocardial infarction patients. CORAMI Registry
  69. Images in intervention Transradial percutaneous coronary intervention for unprotected left main closure during acute myocardial infarction
  70. Efficacy of an Embolic Protection Stent as a Function of Delay to Reperfusion in ST-Segment Elevation Myocardial Infarction (from the MASTER Trial)
  71. Similar outcome of ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention regardless of presence of cardiac surgery on-site
  72. Impact of direct stenting on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry)
  73. Short- and intermediate-term improvement of patient quality of life after transcatheter aortic valve implantation: a single-centre study
  74. Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives
  75. No long-term clinical benefit from manual aspiration thrombectomy in ST-elevation myocardial infarction patients. Data from NRDES registry
  76. Authors’ response
  77. Long-term follow-up of mesh-covered stent implantation in patients with ST-segment elevation myocardial infarction
  78. Impact of intra-aortic balloon pump on long-term mortality of unselected patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock
  79. Primary Angioplasty in Patient with St-Segment Elevation Myocardial Infarction in the Setting of Intentional Carbon Monoxide Poisoning
  80. Ultrasound-guided thrombin injection in the treatment of iatrogenic arterial pseudoaneurysms: Single-center experience
  81. Patient with non-ST-segment elevation myocardial infarction treated by Absorb bioresorbable scaffold implantation
  82. Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry
  83. Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty
  84. Acute left main occlusion during transcatheter aortic valve implantation
  85. Acute myocardial infarction in a patient with chronic renal failure and endocarditis
  86. Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience
  87. Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial
  88. Cardioembolic acute myocardial infarction and stroke in a patient with persistent atrial fibrillation
  89. Early administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry)
  90. Inverted takotsubo cardiomyopathy in a patient with essential thrombocythemia exposed to anagrelide and phentermine
  91. Use of aspiration thrombectomy in a 102-year-old patient with acute inferior ST-segment elevation myocardial infarction
  92. Successful primary angioplasty in patient with ST-segment elevation myocardial infarction caused by large septal branch occlusion
  93. Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
  94. Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry)
  95. Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplasty
  96. Out-of-hospital cardiac arrest in patients treated with primary PCI for STEMI. Long-term follow up data from EUROTRANSFER registry
  97. Evidence for mesh-covered stent implantation in ST-segment elevation myocardial infarction
  98. Tools & Techniques: PCI for acute MI tips and tricks
  99. Effects of short-term anti-inflammatory therapy on endothelial function in patients with non-ST-segment elevation acute coronary syndrome
  100. Taxcor for the prevention of restenosis. Polish multicentre observational study to assess the efficacy and safety of the Genius TAXCOR I stent
  101. Thrombus aspiration followed by direct stenting: A novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial)
  102. Mesh covered stent in ST-segment elevation myocardial infarction
  103. Drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: a mortality analysis from the EUROTRANSFER Registry
  104. Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction
  105. Impact of Multivessel Coronary Artery Disease and Noninfarct-Related Artery Revascularization on Outcome of Patients With ST-Elevation Myocardial Infarction Transferred for Primary Percutaneous Coronary Intervention (from the EUROTRANSFER Registry)
  106. Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry
  107. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction
  108. Angiographic perfusion score assessed in patients with acute myocardial infarction is correlated with cardiac magnetic resonance infarct size and N-terminal pro-brain natriuretic peptide in 6-month follow-up
  109. Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention
  110. Transportation with very long transfer delays (>90 min) for facilitated PCI with reduced-dose fibrinolysis in patients with ST-segment elevation myocardial infarction
  111. Predictors and in-hospital outcomes of cardiogenic shock on admission in patients with acute coronary syndromes admitted to hospitals without on-site invasive facilities
  112. Long-term follow-up of percutaneous peripheral interventions in lower limb arteries in patients with acute coronary syndrome and diabetes
  113. Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER Registry
  114. Impact of Admission Glucose Level and Presence of Diabetes Mellitus on Mortality in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Treated Conservatively
  115. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up
  116. PCI after lytic therapy: when and how?
  117. Patency of infarct related artery after pharmacological reperfusion during transfer to primary percutaneous coronary intervention influences left ventricular function and one-year clinical outcome
  118. Time delay in primary angioplasty: how relevant is it?
  119. More aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservatively
  120. Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: A randomized study
  121. Antiplatelet treatment in non-ST-segment elevation acute coronary syndrome patients undergoing percutaneous coronary intervention (ISAR-REACT 2 insight)
  122. The role of thrombectomy and embolic protection devices
  123. Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals